Table 3 Progression-free survival and overall survival by LCS6 genotype and treatment
LCS6 genotype | N | Arm | Median months | 95% CI | Interaction P value |
|---|---|---|---|---|---|
Progression-free survival | |||||
Wild-type | 154 | A | 7.9 | 7.2-8.5 | 0.63 |
297 | B+C | 7.7 | 7.2-8.3 | ||
Variant | 26 | A | 7.7 | 3.8 – 11.6 | |
58 | B+C | 8.5 | 7.0-10.0 | ||
Overall survival | |||||
Wild-type | 154 | A | 20.4 | 16.5 – 24.2 | 0.50 |
297 | B+C | 18.9 | 16.9 – 20.9 | ||
Variant | 26 | A | 22.3 | 13.2 – 31.4 | |
58 | B+C | 23.5 | 19.9 – 27.1 | ||